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Cytochrome c is a key molecule in mitochondria-mediated apoptosis. It also plays a pivotal role in cell respiration. The switch
between these two functions occurs at the moment of its release from mitochondria. This process is therefore extremely relevant
forthefateofthecell.Sincecytochromec mediatesrespiration,westudiedthechangesinrespiratorychainactivityduringtheearly
stages of apoptosis in order to contribute to unravel the mechanisms of cytochrome c release. We found that, during staurosporine
(STS)- induced apoptosis in PC12 cells, respiration is aﬀected before the release of cytochrome c, as shown by a decrease in the
endogenous uncoupled respiration and an uncoupling event, both occurring independently of cytochrome c release. The decline
in the uncoupled respiration occurs also upon Bcl-2 overexpression (which inhibits cytochrome c release), while the uncoupling
event is inhibited by Bcl-2. We also observed that the ﬁrst stage of nuclear condensation during STS-induced apoptosis does not
depend on the release of cytochrome c into the cytosol and is a reversibile event. These ﬁndings may contribute to understand the
mechanisms aﬀecting mitochondria during the early stages of apoptosis and priming them for the release of apoptogenic factors.
1.Introduction
Mitochondria play a key role in apoptosis triggered by a wide
variety of stimuli since they release important proapoptotic
factors from their intermembrane space. The ﬁrst mitochon-
drial apoptogenic molecule discovered was the hemoprotein
cytochrome c [1]. Cytochrome c is involved in two critical
cell processes. Normally, it acts as mobile electron carrier
shuttlingelectronsbetweenubiquinolcytochromec oxidore-
ductase (complex III) and cytochrome c oxidase (complex
IV) of the respiratory chain allowing cell life. On the other
hand, upon apoptotic induction, cytochrome c is released
from mitochondria in the cytosol where it carries out a
proapoptotic function by binding the adapter protein apop-
tosis protease-activating factor-1 (Apaf1). Consequently, it
promotes, in presence of ATP/dATP, the assembly of the
multiproteic complex apoptosome, which binds and acti-
vates the caspase-9, thereby initiating the activation of a
caspase cascade which leads to apoptotic cell death [2, 3].
Mitochondrial outer membrane permeabilization
(MOMP) and cytochrome c release from mitochondria
during apoptosis are tightly regulated by the proteins of
the Bcl-2 family. This family of proteins includes both anti-
apoptotic members (e.g., Bcl-2 and Bcl-XL) repressing
MOMP and release of apoptogenic factors from mitochon-
dria and pro-apoptotic members promoting MOMP (e.g.,
Bax and Bak, Bid) [4, 5]. However, the detailed mechanisms
of cytochrome c release are still unclear.
The phospholipid cardiolipin (CL) seems to have a key
role in the process of the cytochrome c release [6]. Only 15%
of cytochrome c is free in the intermembrane space, while
most of it is attached to the outer leaﬂet of the mitochondrial
inner membrane with the mitochondrion-speciﬁc anionic
phospholipidCL.Ithasbeenrecentlyfoundthatposttransla-
tional modiﬁcations or interaction with hydrophobic anions
such as CL causes the activation of cytochrome c into a per-
oxidase with selective catalytic competence toward CL [7, 8].
Cytochrome c tightly bound to CL was proposed to possess2 International Journal of Cell Biology
this peroxidase activity and to catalyze CL peroxidation,
most likely by utilizing the high production of reactive
oxygen species (ROS) generated in the mitochondria during
the ﬁrst stages of apoptosis. Cytochrome c has a lower
aﬃnity for peroxidized CL, and peroxidation of CL enables
the dissociation of cytochrome c from mitochondrial inner
membrane allowing the release of cytochrome c from mito-
chondria. CL oxidation is, indeed, mandatory for the release
ofcytochromec [6].However,theﬁnalreleaseofcytochrome
c requires additional steps such as the permeabilization of
the outer membrane. CL is also involved in mitochondrial
outer membrane permeabilization since it enables docking
and activation of some pro-apoptotic Bcl-2 proteins [9–11].
These ﬁndings strongly suggest an active role of the
membrane in modulating MOMP that has been underesti-
mated so far. Cytochrome c is part of the respiratory chain
whose complexes are located across the mitochondrial inner
membrane, and membrane integrity greatly inﬂuences the
respiratory activity of the cells. Based on this considerations,
we analyzed the respiratory changes during apoptosis and
their temporal relationship with the release of cytochrome c
inordertogetinformationusefultounravelthemechanisms
of release of this hemoprotein from mitochondria. We
therefore analyzed the respiratory activity of a rat cell line
of neuronal derivation (pheochromocytoma-12, PC12 cells)
by polarographic measurement of oxygen consumption in
intact cells [12]. The PC12 line was originally cloned from
a transplantable rat adrenal medullary pheochromocytoma.
This cell line manifests many features of sympathicoblasts,
the cells that give rise to postmitotic sympathetic neurons.
Indeed, they respond to nerve growth factor (NGF) by
shifting to a nonproliferating neurite-bearing phenotype
and acquiring many of the properties characteristic of
sympathetic neurons among which electrical excitability. For
this reason the clonal PC12 cell line is widely used for
various studies on neuronal cell diﬀerentiation and function.
During staurosporine- (STS-) induced apoptosis in na¨ ıve
PC12 cells, we observed an uncoupling event preceding
the reduction of cytochrome c oxidase- (COX-) respiratory
activity. Our investigation has also revealed diﬀerent kinetics
of decrease in 2,4-dinitrophenol- (DNP-) uncoupled and
COX-dependent respiration with the former showing, at
very early stage, a faster kinetics of decrease compared with
the latter. This suggests an eﬀect of STS on the respiratory
activity, which is independent of cytochrome c release. This
hypothesis is conﬁrmed by our ﬁnding that overexpression
of Bcl-2 protects from release of cytochrome c and massive
decrease in respiration, while it has no eﬀect on the early
decrease in DNP-uncoupled respiration induced by STS.
2. Results
2.1. Measurement of Respiration in Intact STS-Treated PC12
CellsEarlyDecreaseinDNP-UncoupledRespiration. Sincethe
cytochrome c is part of the respiratory chain as the electron
donor for complex IV, it is expected that its release from
mitochondria during apoptosis would cause changes in the
respiratory activity of the cells. We analyzed the nature and
the extent of these changes by measuring the rate of oxygen
consumption in naive PC12 cells and in naive PC12 cells
undergoing apoptosis by treatment with the protein kinase
inhibitor STS [13, 14].
We measured the oxygen consumption of the cells
(endogenous respiration), the oxygen consumption in pres-
ence of the uncoupler DNP (DNP-uncoupled respiration,
which represents the highest endogenous respiration rate
that cells can reach being free of control by the proton gradi-
ent) and the rate of respiration measured in presence of the
complex III inhibitor antimycin A, the artiﬁcial membrane-
permeant electron donor TMPD (N,N,N ,N -tetramthyl-
1,4-phenylendiamine),andthereducingagentascorbatethat
maintains TMPD in a reduced state (TMPD-dependent
respiration) [12]. Since antimycin A inhibits complex III
and blocks the electron ﬂux upstream of COX, the TMPD-
dependent respiration provides a measure of the COX and
cytochromec-dependentoxygenconsumptionindependent-
ly of the upstream segment of the respiratory chain [15].
TherespirationofbothuntreatedandSTS-treatedPC12cells
resultedbeing100%antimycinA-sensitive(datanotshown).
Upon treatment with STS we observed a time-dependent
decrease in the endogenous, DNP-uncoupled and TMPD-
dependentrespirationrates.After5hroftreatmentwithSTS,
the DNP-uncoupled respiration rate decreased to ∼45% of
the DNP-uncoupled respiration rate of untreated cell and
to ∼28,8% after 9hr of treatment (Figures 1(a) and 2(b)).
TheoxygenconsumptionrelativetoprolongedperiodofSTS
treatment (9h and 24h) is overestimated since, being very
light, it is diﬃcult to collect all dying cells with the usual
centrifugation speed; and it is not advisable to use higher
speed since it would aﬀect the respiration of alive cells.
ThekineticsofdecreaseinTMPD-dependentCOXrespi-
ration rate during STS-treatment was similar to the kinetics
of decrease in endogenous and DNP-uncoupled respiration
rates.However,veryinterestingly,byfocusingontheﬁrstfew
hours of treatment, we observed that, the decrease in DNP-
uncoupled respiration rate was signiﬁcantly faster compared
with the COX-dependent respiration rate decrease. In fact,
after 1hr of STS treatment, the TMPD-dependent respira-
tion rate was decreased only by 4% relative to the rate of
untreated cells, while the DNP-uncoupled respiration rate
was decreased by 15% (Figure 1(b)). This diﬀerence remains
constant with increasing time of STS-treatment. Since the
COX-dependent respiration depends directlyon cytochrome
c and decreases less than the overall uncoupled respiration,
thismeansthattheuncoupledrespirationisaﬀectedbysome
other modiﬁcations than the absence of cytochrome c. This
ﬁnding suggests therefore that there is an impairment of the
mitochondrial respiration soon aftertheapoptotic induction
that is not due to the release of cytochrome c.
2.2. Temporal Correlation between Respiration Changes, Cyto-
chrome c Release and Nuclear Fragmentation during STS-
InducedApoptosis;UncoupledRespirationDropPrecedesCyto-
chrome c Release. To better understand the temporal cor-
relation between decrease in respiration and cytochrome c
release in STS-induced apoptosis we analyzed cytochromeInternational Journal of Cell Biology 3
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Figure 1: Decrease in endogenous, DNP-uncoupled, and TMPD-dependent respiration rates in intact PC12 cells treated with STS; early
decrease in DNP-uncoupled respiration. (a) Oxygen consumption rates of 2μM STS-treated PC12 cells measured at the indicated time
points. Oxygen consumption rates were measured in TD buﬀer (endogenous respiration, End), in TD buﬀer containing DNP (DNP-
uncoupled respiration, DNP) and in TD buﬀer containing DNP, antimycin A, ascorbate, and TMPD (TMPD-dependent respiration,
TMPD). Data are expressed, at each time point, as percentages of the oxygen consumption of untreated cells (0hr). To reduce the variability
of the experiments we calculated the percentages with respect to the control of that particular experiment, and then we averaged the
percentages. Data are expressed as means ± SE (standard error) with n varying at each time point and being 31, 16, 9, 6, 7, 2, and 7,
respectively, for the indicated time points (1h, 2h, 3h, 5h, 9h, 24h). (b) Magniﬁcation of (a) area surrounded by a yellow frame. Note that
the ordinate scale starts at 50%.
c localization by confocal immunoﬂuorescence microscopy.
2uM STS-treatment of PC12 cells promoted nuclear frag-
mentation (Figure 2(a),S T S3 h ;w h i t ea r r o w )a n dc y t o -
chrome c release from mitochondria as clearly resulted
from the diﬀerent immunolocalization of the mitochondrial
marker Hsp60 and cytochrome c (Figure 2(a),S T S3 h ;
yellow arrows). Cell death was detected by DAPI staining
and morphological analysis of nuclei. Figure 2(a) (white
arrow) shows an example of cell considered apoptotic; it
is shrunk and has a fragmented nucleus. By analyzing
several ﬁelds, we calculated the percentage of cells showing
cytochrome c release and the percentage of cells showing
nuclearfragmentation(celldeath)ateachtimepointinorder
to compare these kinetics with the changes in respiration.
Since cytochrome c release from mitochondria during apop-
tosis precedes nuclear fragmentation, we detected cells in
which the cytochrome c had been released from mitochon-
dria while the nucleus was not yet fragmented (Figure 2(a),
STS 3h; yellow arrowheads) but never the opposite. For this
reason,weobtainedakineticsofcytochromecreleaseslightly
more rapid than the kinetics of nuclear fragmentation
(Figure 2(b)). Notably, once released from mitochondria,
cytochromec localizesthroughoutthecelland,assometimes
reported [16, 17], into the nucleus (Figure 2(a),S T S3 h ;
yellow arrows).
Duringtheimmunoﬂuorescencestaining,ahighnumber
of late stage apoptotic cells detached from the dish and were
lost which means that we run the risk to underestimate their
number. To solve this problem we calculated the real per-
centage of apoptotic cells by collecting all of them, also from
the supernatant, through high speed centrifugation and by
staining all nuclei with DAPI. The diﬀerence between the
percentage of cell death calculated by immunoﬂuorescence
on a dish and the one obtained by high speed centrifugation
was used to correct the underestimated percentage of cyto-
chrome c releasing cells evaluated by means of the immun-
oﬂuorescencestaining;deadcellsdetachingduringtheexper-
iment are at the very ﬁnal stages of apoptosis and have al-
ready released cytochrome c [18].
We compared these kinetics with the changes in respira-
tion reported in Figure 1, and for this purpose we expressed
data shown in Figure 2(b) a sp e r c e n t a g eo fc e l l sw i t hm i t o -
chondrially localized cytochrome c and percentage of alive
cells (Figure 2(c)). We observed that the progressively lower
rate of respiration upon STS treatment highly correlates
with the decreased number of alive cells due to apoptotic
death. Interestingly, the decrease of cells with mitochondrial
cytochrome c localization highly correlates with the kinetics
of COX-respiration decrease, but such a decrease is slower
than that observed in DNP-respiration (Figure 2(c)). Such
an analysis strengthens the conclusion that the decrease in
TMPD-dependent respiration is mainly due to cytochrome
c release, while the decrease in DNP-uncoupled respiration
precedes cytochrome c release and must be due to another
mechanism of impairment of the respiratory chain system.
2.3. Respiration Rates, Cytochrome c Localization, and Nuclear
Changes in Bcl-2 Transfected Cells DNP-Dependent Respira-
tion Drop Occurs Also in Absence of Cytochrome c Release. To4 International Journal of Cell Biology
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Figure 2: Cytochrome c release and nuclear apoptosis in STS-treated PC12 cells. (a) Triple labeling confocal immunoﬂuorescence
microscopy of cells untreated (Ctrl), 2μMS T S - t r e a t e df o r3h( S T S3h ) ,o r2μM STS-treated for 6h with 30min zVADfmk (100uM)
pretreatment (zVAD-STS 6h). Pattern of Hsp60 (red), cytochrome c (green), merged patterns (yellow) and nuclear staining by SYTO-X
(grey) of the same representative ﬁelds are shown. (b) Percentage of cytochrome c releasing and apoptotic PC12 cells treated with STS for
the indicated time. Data calculated in 3 independent experiments for each time point. About 1000 cells were considered for each experiment
at each time point. Some SE are small and are within the symbols. Note that the ordinate scale starts at 50%. (c) Comparison between data
shown in Figure 2(b) but expressed as decrease of cells with mitochondrially localized cytochrome c and decrease of alive cells and data
regarding decrease in respiration shown in Figure 1(b).
conﬁrmthattheearlychangesinrespirationobservedduring
apoptosis were really independent of cytochrome c release,
we decided to study the respiration of PC12 cells stably
overexpressing the apoptotic inhibitor Bcl-2 (PC12-Bcl-2
cells), which is known to block the release of cytochrome c
from mitochondria [19, 20]. In fact, PC12-Bcl-2 cells treated
with 2uM STS do not detach from the dish and do not
undergo apoptosis as shown by DAPI staining (Figures 3(a)
and 3(b), nuclei). Moreover, the release of cytochrome c
from mitochondria is inhibited. Indeed, also after prolonged
exposuretoSTS,cytochromec andHsp60maintainthesame
localization in PC12-Bcl-2 cells (Figures 3(a) and 3(b)).
The analysis of the respiration of these cells (Figure 4(a))
shows that Bcl-2 strongly protects against long-term respira-
tory decrease. In fact, after 24h of treatment the uncoupled
endogenous respiration decreases to ∼44.5% of the rateInternational Journal of Cell Biology 5
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Figure 3: Cytochrome c localization and nuclear changes in STS-treated PC12-Bcl-2 cells. (a) Triple labeling confocal immunoﬂuorescence
microscopy of PC12-Bcl-2 cells untreated (Ctrl) and 2μM STS-treated for 24h (STS 24h). Pattern of Hsp60 (red), cytochrome c (green),
and nuclear staining by SYTO-X (grey) of the same representative ﬁelds are shown. (b) Percentage of PC12-Bcl2 cells with mitochondrially
localizedcytochromec andpercentageofalivePC12-Bcl2cellstreatedwithSTSfortheindicatedtime.Datawerecalculatedin3independent
experiments for each time point. About 1000 cells were considered for each experiment at each time point. Note that the ordinate scale starts
at 50%. (c) For quantiﬁcation of cell proliferation, the same number of untreated or STS-treated PC12-Bcl2 cells was plated on several dishes
and counted at the indicated times. Data were calculated in 3 independent experiments for each time point. (d) For quantiﬁcation of cell
proliferation, the same number of STS-treated PC12-Bcl2 cells were plated on several dishes and counted at the indicated times. At 24h the
medium was replaced in order to remove STS. Data were calculated in 3 independent experiments for each time point.
of untreated cells while in absence of Bcl-2, under STS
treatment, respiration decreased to ∼16% of the rate of
untreated cells (or even less considered the overestimation
cited) (Figure 1(a)). The diﬀerence observed for the COX-
dependent respiration is even greater; indeed, after 24h
of treatment, PC12-Bcl-2 cell respiration decreases only to
∼70.7% of the untreated cell rate, while the COX-dependent
oxygen consumption of naive PC12 cells falls to ∼19.8%
of the control. The protection of the respiratory activity
by Bcl-2 is mainly due to the fact that Bcl-2 blocks the
release of the cytochrome c from mitochondria (Figures 3(a)
and 3(b)). However, the early decrease in DNP-dependent6 International Journal of Cell Biology
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Figure 4: Decrease in endogenous, DNP-uncoupled, and TMPD-dependent respiration rates in intact PC12-Bcl-2 cells treated with STS;
early decrease in DNP-uncoupled respiration. (a) Oxygen consumption rates of STS-treated PC12-Bcl-2 cells measured at the indicated
time points. Oxygen consumption rates were measured in TD buﬀer (endogenous respiration, End), in TD buﬀer containing DNP (DNP-
uncoupledrespiration,DNP)andinTDbuﬀercontainingDNP,antimycinA,ascorbateandTMPD(TMPD-dependentrespiration,TMPD).
Data are expressed, at each time point, as percentages of the oxygen consumption of untreated cells (0hr). The data represent the means ±
SE with n varying at each time point and being 17, 20, 12, 2, 3, 6, 8 respectively for the indicated time points (1h, 2h, 3h, 5h, 9h, 24h). (b)
magniﬁcation of (a) area surrounded by a yellow frame. Note that the ordinate scale starts at 50%.
respiration that we have found during the ﬁrst hours of
apoptosis occurs also in Bcl-2-overexpressing cells, although
cytochrome c is not released. Indeed, after 1h of STS
treatment, both in PC12-Bcl-2 and naive PC12 cells, DNP-
uncoupledrespirationdecreasesto ∼84.6%oftherespiration
rate of untreated cells, and the COX-dependent respiration
decreases only to ∼96% of untreated cell respiration. After
two hours of STS treatment, the uncoupled endogenous
respiration falls to ∼72% and ∼74% of the control in PC12-
Bcl-2 and naive PC12 cells, respectively, while the TMPD-
dependentrespirationreachesthe86%ofthecontrolinnaive
PC12 cells and remains almost unchanged in PC12-Bcl-2
cells (92%) (Figures 1 and 4).
Since in PC12-Bcl-2 cells cytochrome c is not released
from mitochondria, this experiment conﬁrms that, in the
ﬁrst phases of apoptosis, the maximum possible respiration
rate achievable in the cell decreases and that the respiratory
chain is impaired independently of the release of cytochrome
c.
Moreover, the comparison between the respiration of
naive PC12 and PC12 cells overexpressing Bcl-2 also shows
thattheratiobetweentheabsolutevaluesofDNP-uncoupled
and endogenous respiration (DNP/End) decreases in PC12
cells immediately after STS treatment, while, in cells overex-
pressing Bcl-2 remains unchanged (Figure 5). This suggests
an early uncoupling respiration event induced by STS that is
prevented by Bcl-2.
The DNP-dependent respiration is uncoupled from the
synthesis of ATP since it occurs when there is a dissipation
of the proton gradient which cannot be used to provide
the energy for the synthesis of ATP. In this condition, the
consumption of oxygen is the highest possible since it is
free of control by the proton gradient and by the synthesis
of ATP. DNP-dependent respiration rate is therefore higher
thannormalendogenousrespirationsinceitisthemaximum
rate achievable by the respiratory chain. For this reason the
ratio beween DNP-dependent respiration and endogenous
respiration (DNP/End) is higher than 1. If the ratio between
DNP and End decreases, this means that endogenous
respiration of the cell tends to become uncoupled. In the
case of PC12-Bcl2 cells the ratio remains constant which
means that there is no uncoupling, while in PC12 cells this
ratio decreases and this indicates an early uncoupling event
(Figure 5).
2.4. Respiration Changes and Cytochrome c Release in STS-
Treated PC12 Cells Are Not Dependent on Caspases and
Do Rely Only on the Apoptotic Role of STS. In order to
deﬁne whether the decrease of respiration, under STS
treatment, was caspase dependent we pretreated PC12 cells
with the broad-spectrum caspase inhibitor z-Val-Ala-Asp
(OMe)-CH2F (z-VADfmk) before STS incubation. While z-
VADfmk blocks apoptosis also after 24h of STS treatment
(Figure 2(a), zVAD-STS 6h, nuclear morphology), it did
not aﬀect the extent of respiration rate reduction (Fig-
ures 6(a) and 6(b)). In fact, the decrease in endogenous,
DNP-uncoupled and COX-dependent respiration upon STS
treatment was perfectly comparable with the respiration
rates measured in PC12 naive cells undergoing apoptosis
(Figures 1(b)). Active caspases are indeed not required for
the mitochondrial release of cytochrome c in STS-induced
cell death [21]. In fact, the analysis of the localization of
cytochrome c by confocal immunoﬂuorescence over several
hours after apoptotic induction shows a gradual releaseInternational Journal of Cell Biology 7
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Figure 5: Uncoupling ratio behaviour in STS treated PC12
and PC12-Bcl-2 cells. Ratio between absolute DNP-uncoupled
oxygen consumption and endogenous respiration expressed in
nanomoles of oxygen consumed per minute and per mg of
cellular proteins (nmolO2/min/mg) of PC12 and PC12-Bcl-2 cells
under 2μM STS-treatment for the indicated time. In detail, for
the indicated time points (0h, 1h, 2h, 3h, 5h), endogenous
respiration oxygen consumption values are 14,82; 13,99; 12,75;
10,12; 11,10nmolO2/min/mg for PC12 cells and 15,82; 12,78;
10,94; 10,98; 9,81nmolO2/min/mg for PC12-Bcl-2 cells. DNP-
uncoupled oxygen consumption values are 25,50; 20,99; 18,36;
15,17; 17,43nmolO2/min/mg and 28,48; 23,14; 19,48; 20,31;
18,64nmolO2/min/mg.
of cytochrome c not aﬀected by zVADfmk pretreatment
(Figure 2(a), zVAD-STS 6h, arrows).
To exclude the possibility that the early reduction of
respiratory activity we detected during the ﬁrst phase of
apoptosis was due to the mere protein kinase inhibition
activity of STS, without any relationship with its apoptotic
induction, we tested bisindolylmaleimide-I (Bis-I), an STS-
analog which is a protein kinase inhibitor without apoptotic
functions [22, 23]. The treatment of PC12 cells with Bis-
I shows that this drug does not induce apoptosis (data
not shown) and does not inhibit the respiration of cells
(Figure 6(c)). The lack of respiratory changes in cells treated
with Bis-I conﬁrms that the decrease in respiration and the
uncoupling of respiration induced by STS correlate with its
apoptotic role.
2.5. Cytochrome c Independent and Reversible Nuclear Con-
densation Induced by STS. As stated before, STS-treated
PC12-Bcl-2 do not die and do not show nuclear fragmen-
tation typical of apoptotic cells also after long treatment
(Figures 3(a) and 3(b)). However, despite the absence of
fragmentation, we can clearly observe a strong condensation
of chromatin (Figure 3(a)), which is very similar to the ﬁrst
stage of condensation observed in STS-treated PC12 cells
and preceding fragmentation (Figure 2(a),S T S3 h ,n u c l e i
yellow arrowheads). STS-treated PC12-Bcl-2 cells bearing
this strong nuclear condensation (Figure 3(a)) are alive since
theyrespire(Figure 4)butdonotreplicate(Figure 3(c));they
do not die but stay in a quiescent state. In fact, when STS is
removed by changing the medium, all nuclei regain a normal
appearance and cells started replicating again (Figure 3(d)).
We conclude that the ﬁrst stage of nuclear modiﬁcation in
STS-induced apoptosis is not dependent on cytochrome c
release and is not a point of no return of the apoptotic
cascade.
3. Discussion
The overall decrease in respiration we detected during STS
treatmentofPC12cellscanobviouslyberelatedtotherelease
of cytochrome c. However, we also found an impairment of
theuncoupledrespirationoccurringintheﬁrstphaseofSTS-
induced apoptosis and preceding the release of cytochrome
c. This phenomenon was also reported in 143B cells [24],
while in anti-Fas antibody-treated Jurkat cells, the loss of
TMPD-dependent and of endogenous respiration occurred
nearly simultaneously and followed cytochrome c release
from mitochondria [15]. This diﬀerence in the sequence of
events might rely on diﬀerent pathways taking place in Fas-
and STS-induced apoptosis.
Regarding the cause of this early respiration impairment
independent of cytochrome c release, we hypothesize a
modiﬁcationofthemitochondrialinnermembraneintegrity
likely to be present at the level of the phospholipid
CL. Indeed, CL is intimately linked to the mitochondrial
bioenergetic machinery and is also actively involved in the
release of cytochrome c. It has also been demonstrated
that the modiﬁcations of the binding between CL and
cytochromecandalsothebindingbetweenCLandsomeBcl-
2 proteins precede and prime mitochondria for MOMP and
for cytochrome c release [8]. CL is crucial for maintaining
the integrity and the function of the mitochondrial inner
membrane and is required for the optimal activity of most
of the respiratory chain complexes. For these reasons, CL
modiﬁcations (e.g., peroxidation by ROS and cytochrome
c peroxidase activity or tBid binding or redistribution
within and between membranes) immediately result in
structural changes of the mitochondrial inner membrane
which destabilize mitochondria and aﬀect the activity of
membrane embedded respiratory chain complexes [6]. This
would impair respiration independently of cytochrome c
release,aswefound.PeroxidationofCLdoesoccurfollowing
a wide variety of apoptotic stimuli also including STS. For
all these reasons we hypothesize that the early changes in
respirations observed might be due to perturbation of the
mitochondrial membrane at the level of CL.
Our analysis also suggests that the ﬁrst stage of apoptosis
is characterized by an early uncoupling event. Indeed, in
the ﬁrst hours of STS treatment of PC12 cells, the ratio
between the absolute DNP-uncoupled and the endogenous
oxygen consumption decreases (Figure 5), indicating a dif-
ference between endogenous and DNP-uncoupled respira-
tion decrease rate (Figure 1). This uncoupling event occurs
after 1h of STS treatment when TMPD respiration is only8 International Journal of Cell Biology
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Figure 6: Decrease in endogenous, DNP-uncoupled, and TMPD-dependent respiration rates in STS-treated PC12 cells pretreated with z-
VADfmk and in Bis-I-treated cells. (a) Relative oxygen consumption rates of 100μM zVADfmk-pretreated, 2μM STS-treated PC12 cells for
the indicated times. Oxygen consumption rates were measured in TD buﬀer (endogenous respiration, End), in TD buﬀer containing DNP
(DNP-uncoupled respiration, DNP) and in TD buﬀer containing DNP, antimycin A, ascorbate and TMPD (TMPD-dependent respiration,
TMPD). Data are expressed, at each time point, as percentages of the oxygen consumption of untreated cells (0hr). Data are expressed as
means ± SE with n varying at each time point and being 8, 6, 6, 2, 3, 2, 3 for 1h, 2h, 3h, 5h, 9h, and 24h, respectively. (b) Magniﬁcation
of the panel (a) area surrounded by a yellow frame. Note that the ordinate scale starts at 50%. (c) Relative oxygen consumption rates of
Bis-I-treated PC12 cells for the indicated times. Data are expressed as means ± SE with n varying at each time point and being 5, 6, and 5 for
1h ,2h ,a n d3hr e s p e c t i v e l y .
slightly aﬀected, and it is therefore presumably independent
of cytochrome c release. However, the uncoupling is blocked
by the overexpression of Bcl-2 (Figures 4 and 5). Therefore,
Bcl-2 does not prevent the early decrease in respiration
induced by STS (Figure 4) but prevents the uncoupling of
respiration, which might be the step following the decrease
of the maximum rate of respiration and ultimately leading
to cytochrome c release. We suggest that the uncoupling of
respiration might correlate with the step of the cytochrome
c release process involving the Bcl-2 family of proteins.
Interestingly, the uncoupling of respiration is known to be
also caused by CL modiﬁcations, supporting our hypothesis
of CL as early target for apoptotic changes in mitochondria.
Our experiments, in addition, show a strong degree
of nuclear condensation (never reaching fragmentation)
occurring in absence of cytochrome c release (Figure 3(a)).
This partial chromatin condensation might be the ﬁrst step
ofnuclearmodiﬁcationsleadingultimatelytofragmentation,International Journal of Cell Biology 9
and it has been reported to involve DNA double-strand
breaks [25, 26]. We assessed that, in na¨ ıve PC12 cells, this
early nuclear condensation occurring in Bcl2-overexpressing
cells is reversible and that it is not a point of no return in the
apoptotic pathway(Figures3(c)and3(d)).Thisconﬁrmsthe
ﬁnding that MOMP inhibitors allow cells with preapoptotic
chromatin condensation to repair their DNA and to return
to a normal nuclear morphology [26].
Finally, we observed that cytochrome c redistributed
within the nuclei once lost its mitochondrial localization
after induction of apoptosis, and, after long STS treatment,
as previously reported [27], it became ﬁnally degraded
(Figure 2(a), zVAD-STS 6h, white arrow). No cells with
cytochrome c localized only into the cytosol were detectable.
This means that the nuclear localization of cytochrome c is
quick,andindeeditoccursnotonlywhenthenucleiarefrag-
mented but also when the chromatin is not yet fragmented
or at a very early stage of condensation (Figure 2(a), yellow
arrows).ThisnuclearcytochromecaccumulationwaszVAD-
independent (Figure 2(a), zVAD-STS 6h).
In conclusion, we found that mitochondrial bioenerget-
ics is perturbed previously and independently of the release
of cytochrome c during apoptosis. This ﬁnding may shed
new light on the mechanisms leading to the release of cyto-
chromec.Indeed,consideringtheinterdependenciesexisting
between bioenergetics and apoptosis [28], their coinvestiga-
tion in a holistic approach is strongly needed.
4.MaterialandMethods
4.1. Cell Line and Culture Conditions. PC12 cells were cul-
tured at 37◦Ci na5 %C O 2 atmosphere in F-12K (GIBCO)
medium supplemented with 2mM L-glutammine, 1,5g/L
sodium bicarbonate, 15% horse serum, 2.5% fetal bovine
serum (FBS), and penicillin-streptomycin. For apoptotic
induction, cells were seeded at 2×105/mL into tissue culture
dishes coated with 20μg/mL poly-L-lysine (Sigma-Aldrich).
After 2 days the medium was replaced, and after 2 hours
2μM STS (Sigma-Aldrich) in DMSO was added. 100uM z-
VADfmk (Kamiya Biochemicals) was added 30min before
STS. Bisindolylmaleimide GF 109203X was purchased from
Calbiochem.
4.2. Quantiﬁcation of Apoptosis. Apoptosis was assessed by
nuclear morphology. At diﬀerent time points upon STS
treatment, both cell ﬂoating in the medium and cells
adherenttothedishwerecollectedbycentrifugation,washed
with PBS, ﬁxed in 4% paraformaldehyde (PFA), and stained
with 1μg/mL of the ﬂuorescent double-strand DNA-binding
dye 4,6-diamidino-2-2phenylindol (DAPI, Sigma-Aldrich)
for 8min. One drop of this preparation was analyzed on
a slide by ﬂuorescent microscopy. Cells with large nuclei
containing uniformly stained chromatin were counted as
alive cells, while cells containing fragmented nuclei and/or
pyknotic nuclei were counted as dead cells. Values were
obtained from 40–50 ﬁelds of 1-2 slides for a total of around
1000 cells/experiments. Each experiment was replicated 6-7
times with similar results.
4.3.Transfection. AhumanBcl-2αcDNA[19]wassubcloned
from SFFV-Bcl-2 n1 into the neomycin resistance marker-
containing plasmid pcDEF3 [29] under the control of the
EF-1a promoter and then used for transfection into PC12
cells by electroporation. Exponentially growing PC12 cells
(107) were resuspended in 0.8mL of PBS, mixed with 18mg
of Bcl-2-pcDEF3 and 5mg of pGL1, and incubated on ice
for 10min. Electroporation was performed with a BioRad
gene pulser by using a setting of 960mF and 300V. Cells
then were incubated on ice for 10min and plated in F12-
K medium supplemented with 15% horse serum and 2.5%
FBS on collagen coated dishes (BIOCOAT). After 48h stable
transfectant overexpressing Bcl-2 (PC12-Bcl-2 cells) was
selectedbyusing0.3mgmLG418(Geneticin;Invitrogen)for
2w e e k s .
4.4. Measurement of Respiration Rates in Intact Cells. PC12
cells were suspended in TD buﬀer (137mM NaCl, 5mM
KCl, 0.7mM Na2HPO4, 25mM Tris-HCl pH 7.4 at 25◦C)
at 3 × 106 cells/mL, and the respiration rate was measured
in an oxygraph (Yellow Spring Instruments, model 5300).
The same measurement was assessed after addition of
40μM DNP or DNP and 20nM antimycin A (Sigma-
Aldrich) or DNP, Antimycin A, 400μMT M P D( F l u k a )
and 10mM ascorbate (Sigma-Aldrich) as described [12].
Oxygen consumption rate was expressed in nanomoles of
oxygen consumed per minute and mg of cellular proteins
(nmolO2/min/mg) as determined by the Bradford procedure
(BioRad) and as percentage of the untreated PC12 cell
respiration. The oxygen consumption rate measured in
presence of cells, DNP, antimycin A, ascorbate, and TMPD
wascorrectedbysubtractionoftheoxygenconsumptionrate
due to the autooxidation of ascorbate/TMPD in absence of
cells [15].
4.5. Confocal Immunoﬂuorescence Microscopy. Cells were
cultured on collagen-coated dishes at a concentration of 5
× 105 cells/mL. After 2 days cells were treated with STS,
then washed with PBS, ﬁxed in 4% PFA in PBS for 10min
at RT, washed, permeabilized with PBS containing 0,4%
Triton X-100 for 5min, and washed again with PBS. After
blocking the cells with PBS containing 2% horse serum (HS-
PBS) for 30min, they were incubated with mouse anticy-
tochrome c monoclonal antibody 6H2.B4 (BD Pharmingen)
diluted 1:300 in HS-PBS and rabbit anti-Hsp60 antiserum
(StressGene) diluted 1:200 for 1h at 37◦C in a humidiﬁed
chamber. Following 3 washes in HS-PBS (5min each), the
cells were incubated with FITC conjugated goat anti-mouse
IgG (Jackson ImmunoResearch Laboratories) diluted 1:200
and lissamine-rhodamine conjugated goat anti-rabbit IgG
(Jackson ImmunoResearch Laboratories) diluted 1:200 for
1h at room temperature. The specimens were washed 3min
in HS-PBS and incubated with SYTOX Green (Molecular
Probes) 25nM for 15min at room temperature. Cells were
washed again 3 times (5min each) in PBS, mounted in10 International Journal of Cell Biology
Fluoroguard antifade reagent (BioRad), and analyzed on a
Zeiss 510 laser scanning microscope.
4.6. Immunoblot Analysis. Same amount of cell lysates were
analyzed by 15% SDS-PAGE. Proteins were then transferred
to a polyvinylidene diﬂuoride (PVDF) membrane (BioRad),
and the membrane was treated for 1h with blocking solution
(0.02% Tween 20, 0.02% NaN3, 5% nonfat milk in PBS)
at room temperature. The membrane was then incubated
f o r4ha t4 ◦C with mouse anti-Bcl-2 monoclonal antibody
(sc-7382) (Santa Cruz Biotechnologies) diluted 1:1000 in
blocking solution. It was then washed 3 times in PBS
(10min each) and 1 time with washing solution (150mM
NaCl, 50mM Tris-HCl pH 7.5) and then incubated for
1h at RT with sheep anti-mouse IgG peroxidase-linked
(Amersham) diluted 1:2000 in washing solution containing
5% nonfat dried milk. Finally the membrane was washed
5 times in washing solution (10min each), and speciﬁc
protein complexes were identiﬁed using Super Signal West
PICO chemiluminescence reagent (Pierce Biotechnology) by
autoradiography.
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